Cvs Health (CVS) EPS (Basic) (2009 - 2026)

Cvs Health has reported EPS (Basic) for 18 years, with the latest figure at $2.31 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Basic) rose 63.83% year-over-year to $2.31; the trailing twelve-month figure through Mar 2026 stood at $2.32 (down 44.76% YoY), and the FY2025 full-year result was $1.4, down 61.85% from the prior year.
• EPS (Basic) for Q1 2026 stood at $2.31, down from $2.33 in the prior quarter.
• The five-year high for EPS (Basic) was $2.33 in Q4 2025, with the low at -$3.13 in Q3 2025.
• Historically, EPS (Basic) has averaged $1.01 across 5 years, with a median of $1.48 in 2023.
• Annual changes were most pronounced in 2023 — EPS (Basic) surged 167.95% — and 2025, when it sank 4571.43%.
• Cvs Health's EPS (Basic) stood at $1.78 in 2022, then dropped by 10.67% to $1.59 in 2023, then declined by 17.61% to $1.31 in 2024, then jumped by 77.86% to $2.33 in 2025, then retreated by 0.86% to $2.31 in 2026.
• The last three EPS (Basic) figures came in at $2.31 (Q1 2026), $2.33 (Q4 2025), and -$3.13 (Q3 2025), per Business Quant data.